Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 4
2017 22
2018 21
2019 9
2020 15
2021 14
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Mutual checking system for assessing trainee skills of thoracic surgery.
Miura N, Matsubara T, Takamori S, Akamine T, Haratake N, Shikada Y, Yamaguchi M, Okamoto T, Takenoyama M. Miura N, et al. Among authors: haratake n. Asian Cardiovasc Thorac Ann. 2021 Oct;29(8):792-797. doi: 10.1177/02184923211025439. Epub 2021 Jun 24. Asian Cardiovasc Thorac Ann. 2021. PMID: 34167323
Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue.
Takamori S, Matsubara T, Haratake N, Toyokawa G, Fujishita T, Toyozawa R, Ito K, Yamaguchi M, Taguchi K, Okamoto T, Seto T. Takamori S, et al. Among authors: haratake n. Front Oncol. 2021 Aug 23;11:704084. doi: 10.3389/fonc.2021.704084. eCollection 2021. Front Oncol. 2021. PMID: 34497761 Free PMC article. Review.
Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC.
Toyozawa R, Haratake N, Toyokawa G, Matsubara T, Takamori S, Miura N, Yamaguchi M, Takenoyama M, Seto T. Toyozawa R, et al. Among authors: haratake n. JTO Clin Res Rep. 2020 Feb 13;1(1):100012. doi: 10.1016/j.jtocrr.2020.100012. eCollection 2020 Mar. JTO Clin Res Rep. 2020. PMID: 34589914 Free PMC article.
Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC.
Toyozawa R, Haratake N, Toyokawa G, Matsubara T, Takamori S, Miura N, Yamaguchi M, Takenoyama M, Seto T. Toyozawa R, et al. Among authors: haratake n. JTO Clin Res Rep. 2020 Feb 11;1(2):100005. doi: 10.1016/j.jtocrr.2020.100005. eCollection 2020 Jun. JTO Clin Res Rep. 2020. PMID: 34589920 Free PMC article. No abstract available.
Prognosis of Early-stage Part-solid and Pure-solid Lung Adenocarcinomas.
Kinoshita F, Toyokawa G, Matsubara T, Kozuma Y, Haratake N, Takamori S, Akamine T, Hirai F, Takenaka T, Tagawa T, Maehara Y. Kinoshita F, et al. Among authors: haratake n. Anticancer Res. 2019 May;39(5):2665-2670. doi: 10.21873/anticanres.13391. Anticancer Res. 2019. PMID: 31092466
79 results